SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Northwest Biotherapeutics Inc.
NWBO 0.250+4.2%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy9/13/2016 2:41:32 PM
   of 759
 
flipper44 Tuesday, 09/13/16 12:55:28 PM
Re: Do Due Dilligence post# 73223
Post # of 73285


Going after low-grade glioma market as well?

Quote:4:25-4:30pm [November 18, 2016] Phase IIa clinical trial evaluating dendritic cell ATIM-32 vaccine for the treatment of low-grade
gliomas
Moughon D, Everson R, Odesa S, Soto H, Billingslea-Yoon E, Sedighim S, Orpilla J, Lin J, Prins R, Liau L -- Abstract to be presented at SNO conference, November 18, 2016.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News